Safety Endpoints with Vadadustat Versus Darbepoetin Alfa in Patients with Non–Dialysis-Dependent CKD: A Post Hoc Regional Analysis of the PRO2TECT Randomized Clinical Trial of ESA-Treated Patients
KIDNEY MEDICINE（2023）
Key words
Anemia,chronic kidney disease,hypoxia-inducible factor,vadadustat,darbepoetin alfa
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined